Transplantation from haploidentical NK alloreactive donors improves EFS. (A) EFS in patients transplanted in relapse from NK-alloreactive versus non-NK alloreactive donors. (B) EFS in patients transplanted in CR from NK alloreactive versus non-NK alloreactive donors.